185 related articles for article (PubMed ID: 37877240)
21. PROTACs- a game-changing technology.
Konstantinidou M; Li J; Zhang B; Wang Z; Shaabani S; Ter Brake F; Essa K; Dömling A
Expert Opin Drug Discov; 2019 Dec; 14(12):1255-1268. PubMed ID: 31538491
[No Abstract] [Full Text] [Related]
22. Mechanistic and Structural Features of PROTAC Ternary Complexes.
Casement R; Bond A; Craigon C; Ciulli A
Methods Mol Biol; 2021; 2365():79-113. PubMed ID: 34432240
[TBL] [Abstract][Full Text] [Related]
23. Recent advancements in the discovery of cereblon-based protease-targeted chimeras with potential for therapeutic intervention.
Singh H; Agrawal DK
Future Med Chem; 2022 Oct; 14(19):1403-1416. PubMed ID: 36047364
[TBL] [Abstract][Full Text] [Related]
24. Native mass spectrometry and gas-phase fragmentation provide rapid and in-depth topological characterization of a PROTAC ternary complex.
Song JH; Wagner ND; Yan J; Li J; Huang RY; Balog AJ; Newitt JA; Chen G; Gross ML
Cell Chem Biol; 2021 Oct; 28(10):1528-1538.e4. PubMed ID: 34081921
[TBL] [Abstract][Full Text] [Related]
25. Crystallization of VHL-based PROTAC-induced ternary complexes.
Wijaya AJ; Farnaby W; Ciulli A
Methods Enzymol; 2023; 681():241-263. PubMed ID: 36764760
[TBL] [Abstract][Full Text] [Related]
26. A beginner's guide to current synthetic linker strategies towards VHL-recruiting PROTACs.
Zografou-Barredo NA; Hallatt AJ; Goujon-Ricci J; Cano C
Bioorg Med Chem; 2023 Jun; 88-89():117334. PubMed ID: 37224698
[TBL] [Abstract][Full Text] [Related]
27. Monitoring and deciphering protein degradation pathways inside cells.
Daniels DL; Riching KM; Urh M
Drug Discov Today Technol; 2019 Apr; 31():61-68. PubMed ID: 31200861
[TBL] [Abstract][Full Text] [Related]
28. High throughput E3 ligase degron binding assays for novel PROTAC ligand discovery.
Guenette RG; Potts PR
Methods Enzymol; 2023; 681():23-39. PubMed ID: 36764759
[TBL] [Abstract][Full Text] [Related]
29. Advances and perspectives of proteolysis targeting chimeras (PROTACs) in drug discovery.
Xi JY; Zhang RY; Chen K; Yao L; Li MQ; Jiang R; Li XY; Fan L
Bioorg Chem; 2022 Aug; 125():105848. PubMed ID: 35533582
[TBL] [Abstract][Full Text] [Related]
30. SPR-Measured Dissociation Kinetics of PROTAC Ternary Complexes Influence Target Degradation Rate.
Roy MJ; Winkler S; Hughes SJ; Whitworth C; Galant M; Farnaby W; Rumpel K; Ciulli A
ACS Chem Biol; 2019 Mar; 14(3):361-368. PubMed ID: 30721025
[TBL] [Abstract][Full Text] [Related]
31. Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead.
Bondeson DP; Smith BE; Burslem GM; Buhimschi AD; Hines J; Jaime-Figueroa S; Wang J; Hamman BD; Ishchenko A; Crews CM
Cell Chem Biol; 2018 Jan; 25(1):78-87.e5. PubMed ID: 29129718
[TBL] [Abstract][Full Text] [Related]
32. E3 ligase ligand optimization of Clinical PROTACs.
Jiang H; Xiong H; Gu SX; Wang M
Front Chem; 2023; 11():1098331. PubMed ID: 36733714
[TBL] [Abstract][Full Text] [Related]
33. Importance of Three-Body Problems and Protein-Protein Interactions in Proteolysis-Targeting Chimera Modeling: Insights from Molecular Dynamics Simulations.
Li W; Zhang J; Guo L; Wang Q
J Chem Inf Model; 2022 Feb; 62(3):523-532. PubMed ID: 35084845
[TBL] [Abstract][Full Text] [Related]
34. A close-up shot of protein-protein docking, from experiment to theory and reverse with the PROTAC performers.
Nguyen KQT; Nguyen HH; Phung HTT; Chung KL; Vu TY
J Biomol Struct Dyn; 2024 Jan; ():1-8. PubMed ID: 38284361
[TBL] [Abstract][Full Text] [Related]
35. Proteolysis-targeting chimeras: A promising technique in cancer therapy for gaining insights into tumor development.
Lv M; Hu W; Zhang S; He L; Hu C; Yang S
Cancer Lett; 2022 Jul; 539():215716. PubMed ID: 35500825
[TBL] [Abstract][Full Text] [Related]
36. The rise of covalent proteolysis targeting chimeras.
Gabizon R; London N
Curr Opin Chem Biol; 2021 Jun; 62():24-33. PubMed ID: 33549806
[TBL] [Abstract][Full Text] [Related]
37. PROTAC-induced Protein Functional Dynamics in Targeted Protein Degradation.
Wu KY; Hung TI; Chang CA
bioRxiv; 2024 May; ():. PubMed ID: 38746111
[TBL] [Abstract][Full Text] [Related]
38. Recent Developments in PROTAC-Mediated Protein Degradation: From Bench to Clinic.
Hu Z; Crews CM
Chembiochem; 2022 Jan; 23(2):e202100270. PubMed ID: 34494353
[TBL] [Abstract][Full Text] [Related]
39. In Silico Modeling and Scoring of PROTAC-Mediated Ternary Complex Poses.
Liao J; Nie X; Unarta IC; Ericksen SS; Tang W
J Med Chem; 2022 Apr; 65(8):6116-6132. PubMed ID: 35412837
[TBL] [Abstract][Full Text] [Related]
40. PROTACs: An Emerging Targeting Technique for Protein Degradation in Drug Discovery.
Gu S; Cui D; Chen X; Xiong X; Zhao Y
Bioessays; 2018 Apr; 40(4):e1700247. PubMed ID: 29473971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
